Skip to content

The application value of "ultra-high sensitivity" cardiac magnetic detection device in the diagnosis of hypertensive heart disease

The application value of "ultra-high sensitivity" cardiac magnetic detection device in the diagnosis of hypertensive heart disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110032
Enrollment
Unknown
Registered
2025-09-29
Start date
2024-07-25
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive heart disease

Interventions

Gold Standard:Ultrasound examination meets one of the following conditions to diagnose hypertensive heart disease: ? Left ventricular mass/height 2.7>50 g/m2 (male) or>47 g/m2 (female)
? Left ventricular mass/body surface area>115 g/m (male) or>95 g/m (female)
? Relative wall thickness>0.43
? Left ventricular end diastolic diameter/height>34 cm/m (male) or>33 cm/m (female)
? Left atrial volume/height 2>18.5 mL/m2 (male) or>16.5 mL/m2 (female).
Index test:Diagnosis of hypertensive heart disease using cardiac magnetic detection device

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old 2. Clinical diagnosis of hypertension (According to the 2018 revised version of the Chinese Guidelines for the Prevention and Treatment of Hypertension, one of the following four criteria must be met: (1) a history of hypertension and current use of antihypertensive drugs; (2) non same day, three consultation room blood pressure, SBP >= 140mmHg and/or DBP >= 90mmHg; (3) 24-hour dynamic blood pressure, average SBP/DBP >= 130/80mmHg, or daytime >= 135/85mmHg, or nighttime >= 120/70mmHg; (4) home self measured blood pressure >= 135/85mmHg.) 3. The subjects voluntarily participate in the study and have signed an informed consent form

Exclusion criteria

Exclusion criteria: 1. Known patients with structural heart diseases such as cardiomyopathy and valve disease, including ischemic cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, congenital heart disease, moderate or severe valve disease, etc. 2. Patients who are experiencing arrhythmia that may affect hemodynamics, including those with tachyarrhythmia, grade II or higher atrioventricular block, sick sinus syndrome, and other severe arrhythmias that have not yet recovered. 3. Individuals who are unable to undergo magnetocardiography due to symptoms such as claustrophobia or physical activity disorders. 4. Due to various reasons, the corresponding inspector cannot cooperate with the research requirements. 5. Any situation that other researchers believe may harm the health of patients, hinder the completion of research, or interfere with research results.

Design outcomes

Primary

MeasureTime frame
The efficacy of the "ultra-high sensitivity" cardiac magnetic detection device in identifying hypertensive heart disease in hypertensive patients;

Secondary

MeasureTime frame
Compared with electrocardiogram, the "ultra-high sensitivity" cardiac magnetic detection device is more effective in identifying hypertensive heart disease in hypertensive patients;

Countries

China

Contacts

Public ContactXiangqing Kong

The First Affiliated Hospital of Nanjing Medical University

kongxq@njmu.edu.cn+86 139 5161 0265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026